Effects of sodium-glucose co-transporter-2 inhibition on pulmonary arterial stiffness and right ventricular function in heart failure with reduced ejection fraction

HIGHLIGHTS

  • who: Sencer Çamcı and Emre Yılmaz from the Department of Cardiology, Faculty of Medicine, Giresun University, Giresun, Turkey have published the Article: Effects of Sodium-Glucose Co-Transporter-2 Inhibition on Pulmonary Arterial Stiffness and Right Ventricular Function in Heart Failure with Reduced Ejection Fraction, in the Journal: Medicina 2022, 58, 1128. of 24/07/2022
  • what: The authors aimed to evaluate the effects of SGLT2 inhibitor treatment on RV function and PAS in HFrEF patients.
  • how: The continuous variables were tested for a normal distribution using the KolmogorovSmirnov test. In the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?